18 results for author:"Piccoli M." in Literature citations
Results Customize
› Repeat search in UniProtKB (6)
| B-type natriuretic peptide levels predict functional capacity in postcardiac surgery patients. Salustri A., Cerquetani E., Piccoli M., Pastena G., Amici E., La Carrubba S., Bakir S., Al Mahmeed W.A. J Cardiovasc Med (Hagerstown) 12:167-172(2011) · Mapped (1) |
| CX3CR1/CX3CL1 axis negatively controls glioma cell invasion and is modulated by transforming growth factor-beta1. Sciume G., Soriani A., Piccoli M., Frati L., Santoni A., Bernardini G. Neuro-oncology 12:701-710(2010) · Mapped (10) |
| NEU3 sialidase strictly modulates GM3 levels in skeletal myoblasts C2C12 thus favoring their differentiation and protecting them from apoptosis. Anastasia L., Papini N., Colazzo F., Palazzolo G., Tringali C., Dileo L., Piccoli M., Conforti E., Sitzia C., Monti E. et al. J. Biol. Chem. 283:36265-36271(2008) · Mapped (2) |
| The proton pump interactor (Ppi) gene family of Arabidopsis thaliana: expression pattern of Ppi1 and characterisation of knockout mutants for Ppi1 and 2. Anzi C., Pelucchi P., Vazzola V., Murgia I., Gomarasca S., Piccoli M.B., Morandini P. Plant Biol. 10:237-249(2008) · UniProtKB (2) |
| PI5KI-dependent signals are critical regulators of the cytolytic secretory pathway. Micucci F., Capuano C., Marchetti E., Piccoli M., Frati L., Santoni A., Galandrini R. Blood 111:4165-4172(2008) · Mapped (9) |
| Lack of association between matrix metalloproteinase-1 (MMP-1) promoter polymorphism and risk of renal cell carcinoma. Piccoli M.F., Figueira M., Andreoni C., Marumo J.T., Schor N., Bellini M.H. Int Braz J Urol 33:622-629(2007) · Mapped (12) |
| The role of mannose-binding lectin gene polymorphisms in women with recurrent bacterial vaginosis. De Seta F., Maso G., Piccoli M., Bianchini E., Crovella S., De Santo D., Caterina P., Guaschino S. Am. J. Obstet. Gynecol. 197:613.e1-3(2007) · Mapped (3) |
| The adaptor molecule CIN85 regulates Syk tyrosine kinase level by activating the ubiquitin-proteasome degradation pathway. Peruzzi G., Molfetta R., Gasparrini F., Vian L., Morrone S., Piccoli M., Frati L., Santoni A., Paolini R. J. Immunol. 179:2089-2096(2007) · Mapped (4) |
| Association of endothelial nitric oxide synthase gene intron 4 polymorphism with end-stage renal disease. Bellini M.H., Figueira M.N., Piccoli M.F., Marumo J.T., Cendoroglo M.S., Neto M.C., Dalboni M.A., Batista M.C., Goes M.A., Schor N. Nephrology (Carlton) 12:289-293(2007) · Mapped (7) |
| Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis. Cerboni C., Zingoni A., Cippitelli M., Piccoli M., Frati L., Santoni A. Blood 110:606-615(2007) · Mapped (2) |
| CIN85 regulates the ligand-dependent endocytosis of the IgE receptor: a new molecular mechanism to dampen mast cell function. Molfetta R., Belleudi F., Peruzzi G., Morrone S., Leone L., Dikic I., Piccoli M., Frati L., Torrisi M.R., Santoni A. et al. J. Immunol. 175:4208-4216(2005) · UniProtKB (1) |
| Arf6: a new player in FcgammaRIIIA lymphocyte-mediated cytotoxicity. Galandrini R., Micucci F., Tassi I., Cifone M.G., Cinque B., Piccoli M., Frati L., Santoni A. Blood 106:577-583(2005) · Mapped (3) |
| p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells. Pisegna S., Pirozzi G., Piccoli M., Frati L., Santoni A., Palmieri G. Blood 104:4157-4164(2004) · Mapped (14) |
| Proline-rich tyrosine kinase 2 and Rac activation by chemokine and integrin receptors controls NK cell transendothelial migration. Gismondi A., Jacobelli J., Strippoli R., Mainiero F., Soriani A., Cifaldi L., Piccoli M., Frati L., Santoni A. J. Immunol. 170:3065-3073(2003) · Mapped (3) |
| SH2-containing inositol phosphatase (SHIP-1) transiently translocates to raft domains and modulates CD16-mediated cytotoxicity in human NK cells. Galandrini R., Tassi I., Mattia G., Lenti L., Piccoli M., Frati L., Santoni A. |
| Activation of Syk tyrosine kinase is required for c-Cbl-mediated ubiquitination of Fcepsilon RI and Syk in RBL cells. Paolini R., Molfetta R., Beitz L.O., Zhang J., Scharenberg A.M., Piccoli M., Frati L., Siraganian R., Santoni A. J. Biol. Chem. 277:36940-36947(2002) · Mapped (4) |
| Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes. Cippitelli M., Fionda C., Di Bona D., Di Rosa F., Lupo A., Piccoli M., Frati L., Santoni A. J. Immunol. 168:1154-1166(2002) · Mapped (3) |
| Cloning of a novel human RNA polymerase II subunit downregulated by doxorubicin: new potential mechanisms of drug related toxicity. Fanciulli M., Bruno T., Cerboni C., Bonetto F., Iacobini C., Frati L., Piccoli M., Floridi A., Santoni A., Punturieri A. |